Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics
Cristiano Chaves(Queen's University), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Mauro Giovanni Carta(University of Cagliari), Rafael G. dos Santos(Clinics Hospital of Ribeirão Preto), Massimo Tusconi(University of Cagliari), Elisa Brietzke(Queen's University), Serdar Dursun(University of Alberta)
Cited by 9
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484